Market Cap: $551.13M
ARS Pharmaceuticals, Inc. (SPRY) is facing significant challenges as it navigates the complexities of the pharmaceutical market, particularly surrounding its leading product, neffy® (epinephrine nasal…
ARS Pharmaceuticals, Inc. ( SPRY ) has encountered significant challenges in recent weeks, highlighting the complexities of launching innovative pharmaceutical products in a competitive market. The co…
